Tommaso Martino De Pas

Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.

G. Giaccone, A. Santoro, V. Bagnardi, 2022, The Lancet. Oncology.

High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study.

G. Curigliano, Z. Ballatore, R. Berardi, 2023, Lung cancer.